Login Register Cart 0
Generic placeholder image

Current Drug Safety

Editor-in-Chief

ISSN (Print): 1574-8863
ISSN (Online): 2212-3911

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Case Report

Dextromethorphan-Induced Altered Level of Consciousness in Children: A Case Series

Author(s): Priyanka Pravinbhai Hotha, Rachna Gupta* and Manish Narang

Volume 18, Issue 3, 2023

Published on: 20 August, 2022

Page: [389 - 392] Pages: 4

DOI: 10.2174/1574886317666220606145809

Price: $65

Abstract

Background: Dextromethorphan, an N-methyl-d-aspartate receptor antagonist, has been used as cold and cough medication. Serious adverse events with therapeutic doses of dextromethorphan are rarely observed. Here, we report three cases of altered levels of consciousness in children with a therapeutic dose of dextromethorphan.

Case Presentation: In all three cases, children developed an altered level of consciousness after taking the first dose of syrup dextromethorphan. Children were unresponsive to any verbal command and pain stimuli. Medical history revealed no pre-existing comorbidities. Other systemic, cardiovascular, abdominal, respiratory and nervous system examinations were normal. All patients were hospitalised and managed with symptomatic and supportive care. Dextromethorphan was stopped. After adequate treatment, all of them recovered satisfactorily. The causality assessment was done based on the World Health Organization Uppsala Monitoring Centre causality scale, and it was probable/likely in all three cases.

Conclusion: In children, an altered level of consciousness could occur with therapeutic doses of dextromethorphan; hence, health care professionals should prescribe dextromethorphan with extreme caution.

Keywords: Adverse drug reaction, Altered level of consciousness, Dextromethorphan, Over the counter medicine, dose, euphoria

« Previous Next »
Graphical Abstract

[1]
Plesan A, Sollevi A, Segerdahl M. The N-methyl-D-aspartate-receptor antagonist dextromethorphan lacks analgesic effect in a human experimental ischemic pain model. Acta Anaesthesiol Scand 2000; 44(8): 924-8.
[http://dx.doi.org/10.1034/j.1399-6576.2000.440805.x] [PMID: 10981567]
[2]
Bolser DC. Central mechanisms II: Pharmacology of brainstem pathways. Handb Exp Pharmacol 2009; 187: 203-17.
[http://dx.doi.org/10.1007/978-3-540-79842-2_10] [PMID: 18825342]
[3]
Gupte S, Gupte N. Pediatric Drug Directory Antitussives. (8th ed.). New Delhi: Jaypee Brothers Medical Publishers 2014; p. 41.
[http://dx.doi.org/10.5005/jp/books/12143_9]
[4]
Unni JC, Nair MKC, Menon PSN, Bansal CP. IAP Pediatric Drug Formulary. (3rd ed.). Mumbai: Indian Academy of Pediatrics 2012; p. 311.
[5]
Weinbroum AA, Rudick V, Paret G, Ben-Abraham R. The role of dextromethorphan in pain control. Can J Anaesth 2000; 47(6): 585-96.
[http://dx.doi.org/10.1007/BF03018952] [PMID: 10875724]
[6]
Chyka PA, Erdman AR, Manoguerra AS, et al. Dextromethorphan poisoning: An evidence-based consensus guideline for out-of-hospital management. Clin Toxicol 2007; 45(6): 662-77.
[http://dx.doi.org/10.1080/15563650701606443] [PMID: 17849242]
[7]
Paul IM, Shaffer ML, Yoder KE, Sturgis SA, Baker MS, Berlin CM Jr. Dose-response relationship with increasing doses of dextromethorphan for children with cough. Clin Ther 2004; 26(9): 1508-14.
[http://dx.doi.org/10.1016/S0149-2918(04)80297-2] [PMID: 15531013]
[8]
Briars LA. The latest update on over-the-counter cough and cold product use in children. J Pediatr Pharmacol Ther 2009; 14(3): 127-31.
[http://dx.doi.org/10.5863/1551-6776-14.3.127] [PMID: 23055900]
[9]
Journey JD, Agrawal S, Stern E. Dextromethorphan Toxicity StatPearls. Treasure Island, FL: StatPearls Publishing 2021. http://www.ncbi.nlm.nih.gov/books/NBK538502/
[10]
Paul IM, Reynolds KM, Kauffman RE, et al. Adverse events associated with pediatric exposures to dextromethorphan. Clin Toxicol 2017; 55(1): 25-32.
[http://dx.doi.org/10.1080/15563650.2016.1240803] [PMID: 27736263]
[11]
LoVecchio F, Pizon A, Matesick L, O’Patry S. Accidental dextromethorphan ingestions in children less than 5 years old. J Med Toxicol 2008; 4(4): 251-3.
[http://dx.doi.org/10.1007/BF03161208] [PMID: 19031376]
[12]
Monte AA, Chuang R, Bodmer M. Dextromethorphan, chlorphenamine and serotonin toxicity: Case report and systematic literature review. Br J Clin Pharmacol 2010; 70(6): 794-8.
[http://dx.doi.org/10.1111/j.1365-2125.2010.03747.x] [PMID: 21175434]
[13]
Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med 2005; 352(11): 1112-20.
[http://dx.doi.org/10.1056/NEJMra041867] [PMID: 15784664]
[14]
Ganetsky M, Babu KM, Boyer EW. Serotonin syndrome in dextromethorphan ingestion responsive to propofol therapy. Pediatr Emerg Care 2007; 23(11): 829-31.
[http://dx.doi.org/10.1097/PEC.0b013e31815a0667] [PMID: 18007217]
[15]
Schwartz AR, Pizon AF, Brooks DE. Dextromethorphan-induced serotonin syndrome. Clin Toxicol 2008; 46(8): 771-3.
[http://dx.doi.org/10.1080/15563650701668625] [PMID: 19238739]
[16]
Baselt RC. Disposition of Toxic Drugs and Chemicals in Man. (7th ed.). Foster City, CA: Biomedical Publications 2004; p. 30.
[17]
Kim EM, Lee JS, Park MJ, Choi SK, Lim MA, Chung HS. Standardization of method for the analysis of dextromethorphan in urine. Forensic Sci Int 2006; 161(2-3): 198-201.
[http://dx.doi.org/10.1016/j.forsciint.2005.12.034] [PMID: 16837153]
[18]
Yoo Y, Lee W, Chung H, Lim M, Kim S, Choi H. Blood concentration of dextromethorphan in fatal overdoses. Annual Report of NISI 1988; 20: 160-4.
[19]
Martinak B, Bolis RA, Black JR, Fargason RE, Birur B. Dextromethorphan in Cough Syrup: The Poor Man’s Psychosis. Psychopharmacol Bull 2017; 47(4): 59-63.
[PMID: 28936010]
[20]
Logan BK, Yeakel JK, Goldfogel G, Frost MP, Sandstrom G, Wickham DJ. Dextromethorphan abuse leading to assault, suicide, or homicide. J Forensic Sci 2012; 57(5): 1388-94.
[http://dx.doi.org/10.1111/j.1556-4029.2012.02133.x] [PMID: 22537430]
[21]
Pugach S, Pugach IZ. Overdose in infant caused by over-the-counter cough medicine. South Med J 2009; 102(4): 440-2.
[http://dx.doi.org/10.1097/SMJ.0b013e31819ba212] [PMID: 19279531]
[22]
Boland DM, Rein J, Lew EO, Hearn WL. Fatal cold medication intoxication in an infant. J Anal Toxicol 2003; 27(7): 523-6.
[http://dx.doi.org/10.1093/jat/27.7.523] [PMID: 14607011]
[23]
Marinetti L, Lehman L, Casto B, Harshbarger K, Kubiczek P, Davis J. Over-the-counter cold medications-postmortem findings in infants and the relationship to cause of death. J Anal Toxicol 2005; 29(7): 738-43.
[http://dx.doi.org/10.1093/jat/29.7.738] [PMID: 16419411]

Rights & Permissions Print Cite
Article Metrics
3
© 2024 Bentham Science Publishers | Privacy Policy